European Investment Bank (HQ)

Treefrog Therapeutics (IEU TI)

Last update: Dec 6, 2024 Last update: Dec 6, 2024

Details

Location:France
France
Status:Approval
Sectors:Health, Research & Innovation
Languages:English
Contracting authority: TreeFrog Therapeutics
Contracting authority type:Supplier / manufacturer
Eligibility:Unknown
Budget: EUR 97,000,000
Date posted: Dec 2, 2024

Attachments 0

Associated Awards

Project cycle timeline

STAGES
EARLY INTELLIGENCE
PROCUREMENT
IMPLEMENTATION
Cancelled
Status
Programming
Formulation
Approval
Forecast
Open
Closed
Shortlisted
Awarded
Evaluation

Description

TREEFROG THERAPEUTICS (IEU TI) Reference: 20230674 Release date: 2 December 2024 Promoter – Financial IntermediaryTREEFROG THERAPEUTICS SAS LocationFrance DescriptionThe promoter is a biotech company that develops allogeneic cell therapies using human ind
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 850+ sources of tenders and grants published by donors, development banks, foundations, and international financial institutions (IFIs) are available here.
Similar tenders
By Locations
Funding agency:
EIB
Status:
approval
Location:
France
By Sectors
Funding agency:
EIB
Status:
approval
Location:
Germany
Funding agency:
EIB
Status:
approval
Location:
Denmark
tender Background

About the Funding Agency

The European Investment Bank (EIB) is the lending arm of the European Union. The EIB is the biggest multilateral financial institution in the world and one of the largest providers of climate finance.

The EIB works closely with other EU institutions to foster European integration, promote the development of the EU and support EU policies in over 160 countries around the world.

Through EIB Global, set up in 2022 to increase the impact of our development finance, the EIB helps address global challenges and creates growth and opportunity on all continents.

About the Sectors

Health

Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.


Key areas:
  • Healthcare services and facilities
  • Public health and disease prevention
  • Medical equipment, supplies, and services

Research & Innovation

Focuses on collecting data, generating new knowledge, and applying it to develop improved methods, technologies, products, and solutions across sectors.


Key areas:
  • Scientific research, studies, and investigations
  • Innovation programs and applied R&D initiatives
  • Technology development
  • Space-related research and exploration themes

Locations

France

France maintains extensive high-speed rail, highway, port, and energy infrastructure to support its diversified industrial and service economy. Investment priorities include rail network upgrades, renewable energy expansion, and low-carbon urban mobility. Infrastructure financing relies on national budgets, EU funds, and PPP frameworks. Decarbonization goals, regional equity, and digital modernization guide future development.

Nr. of tenders: 16304
Nr. of grants: 16097
Nr. of donors: 841
Nr. of jobs: 132
Frequently Asked Questions
Haven't found what you're looking for? Get in touch with us using our contact page.
Where can I find international tenders?
DevelopmentAid aggregates international tenders from major donors, development banks, UN agencies and governments in one searchable platform.
Who can apply for tenders listed on DevelopmentAid?
Tenders are typically open to consulting firms, NGOs, companies, and sometimes individual consultants, depending on the eligibility criteria set by the donor.
How do I apply for a tender?
DevelopmentAid does not submit tenders on your behalf. Each tender listing includes official documents and instructions explaining where and how to apply directly to the contracting authority.
What documents are usually required for a tender application?
Most tenders require a technical proposal, financial offer, company profile, references, and legal documents. Exact requirements are listed in each tender notice.